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The unprecedented outbreak of Ebola in West Africa resulted in over 28,000 cases and 11,000 deaths, 
underlining the need for a better understanding of the biology of this highly pathogenic virus to 
develop specific counter strategies. Two filoviruses, the Ebola and Marburg viruses, result in a severe 
and often fatal infection in humans. However, bats are natural hosts and survive filovirus infections 
without obvious symptoms. The molecular basis of this striking difference in the response to filovirus 
infections is not well understood. We report a systematic overview of differentially expressed genes, 
activity motifs and pathways in human and bat cells infected with the Ebola and Marburg viruses, 
and we demonstrate that the replication of filoviruses is more rapid in human cells than in bat cells. 
We also found that the most strongly regulated genes upon filovirus infection are chemokine ligands 
and transcription factors. We observed a strong induction of the JAK/STAT pathway, of several genes 
encoding inhibitors of MAP kinases (DUSP genes) and of PPP1R15A, which is involved in ER stress-
induced cell death. We used comparative transcriptomics to provide a data resource that can be used to 
identify cellular responses that might allow bats to survive filovirus infections.
An Ebola virus (EBOV) outbreak in West Africa of unprecedented severity resulted in over 28,600 cases and 
11,300 deaths as of April 2016 (http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/previous-case-counts.
html). EBOV and Marburg virus (MARV) are closely related filoviruses, with a nucleotide identity of 49.5%. 
They contain single-stranded RNA genomes with a negative orientation that are approximately 19 kb in size and 
encode seven structural proteins1. The natural hosts of filoviruses are presumed to be bats2, which may be the 
origin of the recent EBOV outbreak in West Africa3. Rousettus aegyptiacus is the natural reservoir of MARV4–6, 
and it survives MARV infections without any signs of the disease7,8. However, humans with filovirus infections 
experience a severe fever and vascular leakage, with high fatality rates9. Surprisingly little is known about the 
response of human cells to EBOV and MARV infections, and the response in bat cells has not been investigated 
at all. Barrenas et al.10 used a next-generation sequencing approach to understand the cellular immune response 
of vaccinated cynomolgus macaques after an EBOV challenge. Microarray-based studies have described the dif-
ferential expression of several known cellular genes after EBOV infections in mice and rhesus monkeys11–14. 
However, the overall response of human and bat cells to filovirus infections is not yet known. Key proteins in 
the infection process and their regulatory circuits have not been defined, and the transcriptional landscape of 
non-coding RNAs (ncRNAs) and alternative mRNA isoforms is unexplored. Cellular targets are an attractive 
alternative for the development of antiviral drugs because viruses cannot adapt to a change in the host cell as 
easily as they can develop a resistance to an antiviral drug over the course of treatment15,16. To establish effective 
antiviral strategies, it is necessary to understand how the infected cells respond to filovirus infections and how 
this response differs between bats and humans. We explored the cellular regulatory response mechanisms by 
sequencing the full transcriptomes of immortalized cells of human and bat origin at three different time points 
post infection (p.i.). We constructed a full de novo transcriptome assembly (see Materials and Methods) based on 
the RNA-Seq data of R. aegyptiacus.
Here, we provide a systematic report on (1) a genome-wide analysis of EBOV, MARV, human, and bat tran-
scripts, as well as (2) single genes that show strong differential regulation, (3) the regulatory transcription factors, 
and (4) the corresponding pathways that are involved in the response to EBOV and MARV infections. We focus 
on the transcriptional differences and similarities between EBOV- and MARV-infected human and bat cells.
Materials and Methods
Cells and RNA extractions. We infected 4 × 105 HuH7 cells17 (a human hepatoma cell line) and 
4 × 105 R06E-J cells18 (an embryonic cell line from R. aegyptiacus) with EBOV (Ebola virus strain Zaire, Mayinga, 
GenBank: NC_002549) or MARV (Lake Victoria Marburg virus, Leiden, GenBank: JN408064.119) at a multiplic-
ity of infection (MOI) of three (Fig. 1A). We used HuH7 cells because EBOV infections in humans induce the 
majority of their histopathological features in the liver, and these cells are highly susceptible to filovirus infec-
tions20. We used immortalized cells because primary cells from bats (macrophages and dendritic cells) are not 
available in the large quantities we required for our RNA-Seq analyses (9 samples from each cell type). Our anal-
yses consisted of computational and extensive manual investigations as shown in Fig. 2. At 3, 7 and 23 h p.i., cells 
were harvested, and total RNA was isolated using an RNeasy Mini Kit (QIAGEN) according to the manufacturer's 
instructions. These time points correspond to the different stages of the viral replication cycle (Fig. 3). Replication 
and transcription take place after 3 h, proteins are produced at 7 h, which may regulate further transcription, 
and a complete replication cycle occurs after 23 h. DNaseI digestion was performed. At each time point, RNA 
was also isolated from non-infected (Mock) control cells. Quality controls were performed to ensure proper 
infection rates and viral propagation. Real-time PCR was used to detect filovirus RNA (polymerase genes)21 
and to demonstrate the amplification of viral RNA over the time course of the infections (Fig. 1B). Ct-values are 
inversely proportional to the amount RNA detected, and these values for the MARV-infected HuH7 cells at 3 
and 7 h p.i. were lower than the values for the MARV-infected R06E-J cells. The Ct-values for the EBOV-infected 
cells showed no clear difference. An immunofluorescence analysis (IFA) of the cells was performed using mouse 
monoclonal antibodies directed against nucleoproteins of EBOV (B6C5, 1:20) and MARV (59-9-10, 1:100). An 
anti-mouse secondary antibody coupled with Alexa 594 (1:500) was used to detect these viral nucleoproteins, 
and DAPI (4′ ,6′ -diamidino-2-phenylindole) staining was used to visualize cell nuclei (1 mg/ml, 1:2000). IFAs of 
the MARV and EBOV nucleoproteins revealed that a MOI of 3 was sufficient to initially infect a high percentage 
of cells (90% of human and bat cells infected with EBOV, 70% of bat cells and 99% of human cells infected with 
MARV, Fig. 1C/D). The quantity and quality of the RNA was assessed using a NanoDrop spectrophotometer and 
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an Agilent Bioanalyzer. Nine samples at different time points were generated from human cells (HuH7-Mock-3h, 
HuH7-Mock-7h, HuH7-Mock-23h, HuH7-EBOV-3h, HuH7-EBOV-7h, HuH7-EBOV-23h, HuH7-MARV-3h, 
HuH7-MARV-7h, HuH7-MARV-23h) and bat (R06E-J-Mock-3h, R06E-J-Mock-7h, R06E-J-Mock-23h, R06E-J-
EBOV-3h, R06E-J-EBOV-7h, R06E-J-EBOV-23h, R06E-J-MARV-3h, R06E-J-MARV-7h, R06E-J-MARV-23h).
Sample preparation and sequencing. The total RNA of the 18 samples was shipped to LGC Genomics 
for the construction of cDNA libraries. Ribo-Zero was used for rRNA depletion, and the Illumina TruSeq kit was 
used for library construction. Illumina sequencing was performed in a 2 × 100 nt paired-end mode on a HiSeq 
2000 system. R06E-J cells were stimulated with interferons, PolyIC or thapsigargin to mimic the induction of the 
interferon system or a stress response by the endoplasmic reticulum (ER) of the cells. Prior to stimulation, R06E-J 
cells were examined for interferon competence via a vesicular stomatitis virus (VSV) bioassay. The cells secreted 
cytokines after PolyIC transfection, and those cytokines partially protected R06E-J cells from VSV infection (data 
not shown). RNA was isolated from these cells, pooled with the 9 previously mentioned R. aegyptiacus cell sam-
ples and shipped to GATC Biotech for normalization and sequencing on an Illumina MiSeq system (2 × 300 nt 
mode). This library of longer paired-end reads was used to improve the de novo transcriptome assembly of 
R. aegyptiacus. All reads were preprocessed based on their Phred quality score. At the 3′ end, bases with a quality 
score < 20, a 5′ -bias and poly-A tails were removed with PRINSEQ-lite22 (v0.20.3). Quality was assessed and 
controlled before and after processing with FastQC23 (v0.10.1).
Genome and annotation data. The human genome GRCh37/hg19 was downloaded from the UCSC24 ftp 
server (ftp://hgdownload.cse.ucsc.edu/goldenPath/hg19/). The annotation data were obtained from the NCBI 
(GRCh37 patch release 5) and Ensembl (GRCh37 release 75). The genomic sequence of Pteropus vampyrus 
(Pva, GCA_000151845.1), the closest related species to R. aegyptiacus (both Megachiroptera) and with well 
established annotation files, was downloaded from the UCSC site (ftp://hgdownload.cse.ucsc.edu/goldenPath/
pteVam1/) and used for the homology search. The genome sequence of R. aegyptiacus was published in early 
2016 by the Boston University School of Medicine. We used all scaffolds and the corresponding annotation data 
downloaded from the NCBI database (ftp://ftp.ncbi.nlm.nih.gov/genomes/Rousettus_aegyptiacus/) for mapping 
and differential gene expression analysis. The genomic sequence and annotation data for the Zaire Ebola virus 
(KM034562.1) were extracted from the UCSC Ebola Genome Portal (ftp://hgdownload.cse.ucsc.edu/
goldenPath/eboVir3/), which is based on the 2014 West African outbreak25. Genome and annotation data for the 
Lake Victoria Marburg virus Leiden (JN408064.1) were obtained from the NCBI-GenBank database.
De novo transcriptome assemblies. The nine HiSeq libraries for H. sapiens and R. aegyptiacus under-
went quality control assessments and were used for transcriptome assembly (see electronic supplement, Table 
ES1A). Long reads of the pooled MiSeq libraries were included in the assembly process for R. aegyptiacus. For 
Figure 1. Monitoring sample preparation. (A) HuH7 and R06E-J cells were infected with MARV or EBOV 
(MOI = 3) or left uninfected (Mock). Samples were collected after 3, 7 and 23 h post infection (p.i.). (B) RNA 
of infected and uninfected cells was isolated at 3, 7 and 23 h p.i., checked for quality and quantity, and filovirus-
specific real time PCR was performed according to Panning et al.21. (C,D) To determine the number of infected 
cells, immunofluorescence analyses were performed with infected cells grown on one coverslip within each 
well used for RNA preparation. Infected cells were visualized (red) using mouse monoclonal antibodies against 
EBOV (C) or MARV (D) nucleoproteins and fluorescently tagged secondary antibodies. DAPI staining was 
used to visualize cell nuclei (blue). Ct-cycle threshold.
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Figure 2. Methods pipeline. (1) Data acquisition: Total RNA from HuH7 and R06E-J cell lines 3, 7 and 
23 h p.i. was depleted of ribosomal RNA and sequenced. We controlled the quality and trimmed the data with 
PrinSeq and FastQC. (2) For bat RNA, we assembled a de novo transcriptome by adding pooled MiSeq 
to HiSeq data using various assembly tools and parameter settings. (3) Mapping was performed for Mock-, 
EBOV-, and MARV-treated cells onto human/bat genomes and the bat transcriptome with segemehl and 
TopHat. (4) Differential gene expression analysis was performed by counting uniquely mapped reads and 
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the bat HiSeq libraries, 372,082,040 paired-end reads were assembled de novo with Velvet26 (v1.2.10), fol-
lowed by Oases27 (v0.2.08), the ABySS/TransABySS28,29 pipeline (v1.5.1/v1.4.8), SOAPDenovo-Trans30 
(v1.0.3) and Trinity31 (v20131110) using default parameters and multiple k-mer values (25/35/45/55/65/75). 
R. aegyptiacus-derived MiSeq paired-end reads (38,028,488) were preprocessed and assembled using Mira32 
(v4.0.0). The resulting contigs from each assembly tool were merged together and clustered based on sequence 
similarities using CD-HIT-EST33 (-c 0.95, v4.6) to improve the quality of the final assembly. The final R. 
aegyptiacus assembly contained 977,787 contigs (human: 986,920 contigs), which is similar to the results of Lee et 
al.34. Of these, 277,595 contigs had a length greater than 1,000 bp. The bat assembly had a maximum contig length 
of 36,073 bp with an N50 of 3,923. We used QUAST35 (v2.3) to calculate several statistics for the independent and 
merged transcriptome assemblies (Table ES1B).
A comparison between the genome and de novo transcriptome assemblies of humans and bats. 
To assess the quality of our de novo transcriptome assemblies, we used various read count thresholds over all 
mapped HuH7 and R06E-J samples (Table S3) to extract transcript subsets from the H. sapiens and R. aegypti-
acus genomes, respectively. We denoted these filtered subsets as expressed and blasted (E-value < 10−10) them 
against the de novo transcriptome assemblies of the human or bat cells. We defined a transcript (derived from the 
genomic sequence) as valid, and therefore correctly assembled, if we obtained a minimum of one blast hit with an 
alignment length > 90% of the query. For the human transcriptome assembly, we found between 93.0% and 98.1% 
of the expressed transcripts, and for R. aegyptiacus 81.3–94.0%. Therefore, the transcriptome assemblies were of 
sufficient quality. The results for different transcript subsets are shown in Table S3. Most of the missing transcripts 
can be explained by a low read coverage in comparison to the length of the transcript or a non-uniform distribu-
tion of reads along the transcript. These transcripts may be assembled as partial contigs (alignment length ≤ 90%). 
The higher number of valid transcripts derived from the human genome can be explained by its better annotation 
and assembly status compared to that of the relatively new R. aegyptiacus genome at the scaffold level.
Genome and transcriptome mapping. RNA-Seq data for the HuH7 and R06E-J samples were mapped 
to the concatenated virus-host genome file (for each combination of the two viruses and three genomes/tran-
scriptomes) in the following two ways: (1) using TopHat36 (v2.0.11) with the default parameters and (2) using 
segemehl37 (v0.1.9) with the split read option -S. The indexing and sorting of the SAM files was performed 
using samtools (v0.1.19). The ViennaNGS38 toolbox (v0.10) was used for processing and visualization of the 
mapped RNA-Seq data. Uniquely mapped reads aligned by TopHat were used for all statistical calculations and 
differential gene-expression analyses. The segemehl mappings were used to support the detailed analyses of 
special splice variants because of the tool’s capability for mapping multi-split reads. The read mapping rates and 
statistics can be found in Table S1. Although we observed some differences for some genes (e.g., NPC1) regarding 
their read counts between the R. aegyptiacus genome and transcriptome assembly, the calculated fold changes 
used in the downstream analyses differed only slightly among all genes.
De novo transcript annotation. We used Cufflinks39 (v2.2.1) in de novo mode to predict tran-
script loci based on the TopHat mappings of all HuH7 samples. Cuffmerge was used to combine the 
Cufflinks-assembled transcripts into a final transcriptome assembly of 18,391 locations for the human genome.
Differential gene expression analysis. For a differential gene expression analysis of hg19, we used reads 
of Mock, EBOV and MARV samples uniquely mapped by TopHat together with the gene annotation data from 
the NCBI. Raw read counting was performed using BEDTools40 (v2.21.0) multicov with the split option. 
The resulting read counts were directly passed to DESeq41 in the R/Bioconductor package (v2.14). Due to the 
lack of replicates, we performed pairwise comparisons between all of the different infection conditions and time 
points with a false discovery rate of 0.1. To compare the characteristics between HuH7 and R06E-J cells at 3, 7 and 
23 h p.i., we used the EBOV and MARV samples at the identical time points as replicates in the DESeq analysis 
(padj ≤ 0.1). In addition to using gene annotations from the NCBI, we processed the de novo gene loci obtained 
from Cufflinks in an identical manner. Furthermore, we used Cuffquant and Cuffnorm to calculate 
FPKM values for each locus from the Cuffmerge -G results. In addition to the normalized read-count-based 
method, we calculated the maximum read peak for each gene and sample using BEDTools genomecov  
(-d -split). We used the notation “= ” when the difference between the two samples was < 15%, “↑ /↓ ” when 
there was up to a two-fold difference, and “n↑ ” when the difference was up to n-fold (greater than 2-fold).
applying a DESeq analysis. The results were used for clustering and scatter/group plot analyses. (5) Homology 
searches in bats were performed for all significantly differentially expressed genes from (4) and for the 
genes that were presumed to be involved in the response to infection based on the literature and an enriched 
pathway analysis. The R. aegyptiacus genome and coding sequences from P. vampyrus were used to validate 
and detect homologous sequences in the bat transcriptome. Detected homologs were used for the differential 
gene-expression analysis. We also investigated the quality of the transcriptome assembly by comparing the 
human and R. aegyptiacus genomes with the corresponding assembly. (6) During the manual inspection, we 
identified the synonyms of gene names and noted their existence in the relevant pathways. Each candidate 
gene was manually investigated in the IGV and UCSC browsers for the human and bat samples from all time 
points. We report the conservation of genes according to the 100 Species Vertebrate Multiz Alignment to chimp, 
mouse, dog, elephant and chicken sequences. We searched for nucleotide modifications (differential SNPs, 
posttranscriptional modifications), intronic transcripts and regulators, alternative splicing and isoforms, and 
upstream and downstream transcript characteristics.
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Clustering of differentially expressed genes. Fold changes in gene expression were calculated by add-
ing a pseudocount of 1 to the raw read counts of each gene. Differentially expressed genes in infected cells, com-
pared to their expression in their Mock control cells, were determined using the DESeq package as described 
above, and only genes with padj < 0.1 were considered differentially expressed for a particular contrast (infection 
versus Mock). For the clustering of fold changes in gene expression, the log2-fold change (FC) for each gene g 
was calculated as log2(ginfection) − log2(gmock). The log2-fold changes in the expression of genes having a log2-fold 
change greater than five in at least one of the contrasts were visualized via hierarchical clustering. Euclidean dis-
tances and the Ward method for agglomeration were used (Figure ES2A).
Identification of co-regulated genes. To compare the differential gene expression for the Mock/EBOV 
and Mock/MARV treatments in HuH7 and R06E-J cells, log2-fold changes, as computed by DESeq, were visu-
alized using scatter plots in R (x-value: FC of Mock/EBOV; y-value: FC of Mock/MARV). The scatterplots were 
overlaid with contour plots for a two-dimensional kernel estimate (kde2d; MASS package) using the default 
parameters. Outliers are labeled with their respective gene names in the electronic supplement (Figure ES4B).
Search for human-gene homologs within bat transcripts. To compare human and bat genes, we 
defined homologous loci between human genes and the transcripts in the R. aegyptiacus assembly. A direct com-
parison between human genes and R. aegyptiacus transcripts led to several unidentified orthologous pairs. To 
improve ortholog detection, we used the annotated orthologs of P. vampyrus from Ensembl to act as an inter-
mediate between the two species. Sequence comparisons were performed using BLASTn+ (v.2.2.27+ ), and hits 
under the restrictive E-value threshold of < 10−50 were considered orthologs. We defined homologous genes 
between the human and recently published R. aegyptiacus genomes.
Comprehensive gene analysis. We obtained a comprehensive set of candidate genes based on more than 
600 significantly differentially expressed genes identified by the DESeq analysis combined with ~900 genes 
extracted from a literature search and a review of immune system-related pathways. We manually investigated 
differential gene expression, changes in expression profiles, nucleotide changes, conservation in other species, 
intron-exon structures, alternatively spliced isoforms, intronic transcripts and 5′ -UTR/3′ -UTR discrepancies 
with the help of the UCSC and IGV42 (v2.3.39) browsers. Each gene, its synonyms, functional information, 
screenshots of genomic locations, isoforms, fold changes and maximum read counts are listed in the electronic 
supplement (nine samples per species).
Figure 3. Human HuH7 cells support an earlier onset of filoviral RNA synthesis than bat R06E-J cells. 
Attachment of the virions to the cell surface leads to cell mediated macropinocytosis93. Within one hour after 
attachment to the host cell, Ebola is endocytosed94, viral transcription can be detected at 2–4 h p.i.95, and 
newly synthesized proteins can be detected via IFA at 6–10 h p.i. Mature nucleocapsids primed for transport 
are present at 10–12 h p.i. (Materials and Methods). The first replication cycle is finished after 15–18 h, when 
virions are released from the host cells. Host cells die between 2 to 7 days. Between 3 and 7 h p.i. of EBOV-
infected R06E-J cells, we observed an ~4.8X increase in the number of reads that mapped uniquely to the EBOV 
genome. This indicates that EBOV genes are rapidly replicated and transcribed in the bat cells in the first 4 h p.i. 
(see Table S2 for normalized read counts). We observed a further 41X increase in reads between 7 and 23 h p.i. 
in R06E-J cells. So, this RNA synthesis rate slows down within this next 16 h (compared to 4.8X4 ≃ 530X). In 
comparison, unique reads mapping to the EBOV genome in HuH7 cells increased 15.6X between 3 and 7 h p.i. 
and a further 15.5X in the following 16 h. This result indicates a significant increase in the RNA synthesis rate of 
viral RNAs in the first few hours and a marked decrease in the following hours.
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Pathway enrichment. We examined which of the differentially expressed genes were over-represented 
in KEGG database43 pathways. Gene set enrichment analyses were performed using a hypergeometric test. 
FDR-corrected p-values were significant at 0.05. We set the threshold to a value of p < 0.1 using a hypergeometric 
test and FDR corrections44. The evaluation was performed with the R-package GAGE45 to obtain KEGG pathway 
information and with pathview46 to allow for visualization.
Motif activity response analysis. A motif activity response analysis with MARA was performed as pre-
viously described47 using the reads uniquely mapped in TopHat as discussed above. We performed MARA on 
the EBOV and MARV samples separately to obtain independent motif rankings and target predictions for each 
virus. We also performed one analysis that considered all samples at once to compare the motif activity changes 
observed after EBOV and MARV infections. The activities obtained from this analysis were used to create the 
activity change comparison plots. To relate the activity of a motif m in virus-infected cells (Am,Virus) to its activity 
in the corresponding Mock control (Am,Mock), the activity change (Am,Δ) was calculated as follows:
= −∆A A Am m Virus m Mock, , ,
with the error calculated as:
= +∆E E Em m Virus m Mock, ,
2
,
2
The fast-track, in-silico “Fight against Ebola”. After the start of the 2014 outbreak, we decided to speed 
up our analysis, which otherwise would have taken up to three years. To accomplish this, 40 scientists with expe-
rience in analyzing RNA-Seq data came together to “Fight against Ebola” and manually investigated each gene. 
During this “hackathon”, we investigated 1,500 genes (7.5% of human protein-coding genes). Each gene was ana-
lyzed in detail using the IGV and UCSC browsers. The gene, its synonyms, functional information, screenshots of 
genomic locations, isoforms, fold changes and maximum read counts can be found in the electronic supplement 
(http://www.rna.uni-jena.de/supplements/filovirus_human_bat/igo.php).
qRT-PCR. We repeated the infection of HuH7 and R06E-J cells and isolated RNA for qRT-PCR analyses. 
An IFA of these cells (Figure S7E) revealed that the infection rates were lower than in the previous experiment 
used for RNA-Seq. Only ~40% (~70%) of the R06E-J cells were infected with EBOV (MARV) in comparison 
to ~90% (~70%) in the first experiment (Fig. 1C). The infection rates were only slightly lower for HuH7 cells 
(Figure S7E). RNA was isolated and reverse transcribed with random hexamers. For qRT-PCR analyses of NPC1 
and TLR3 gene expression, degenerate primers that amplified both the human and the bat mRNA sequences 
were used. HAVCR1 gene expression was measured using human- and bat-specific primers. Expression values 
were normalized to 18S rRNA levels. All primer sequences are listed in File ES7A. qPCRs were performed on an 
Applied Biosystems 7500 Real-Time PCR System using SYBR Green chemistry (iTaq mix, BioRad) according to 
the manufacturer’s instructions. Mean values from triplicate analyses were calculated and quantified with the sys-
tem’s built-in software according to standard curves constructed for each amplicon from serial cDNA dilutions. 
Relative quantification values, melting curves and agarose gel pictures for the three genes are presented in the 
electronic supplement, Section ES7.
Results and Discussion
Differences in early viral replication velocities. By comparing viral RNA levels in HuH7 and R06E-J 
cells, we determined that EBOV and MARV replicate more rapidly in HuH7 than in R06E-J cells between 3 and 
7 h p.i. RNA synthesis slowed down in both species in the subsequent 16 h (Fig. 3), and transcript levels were 
nearly identical at 23 h p.i. (Table S2). The EBOV and MARV viral proteins were more abundant in HuH7 than 
in R06E-J cells at 7 h p.i. and were present at similar levels at 23 h p.i. (Fig. 1C,D) as determined using IFAs. Early 
increases in the levels of viral RNA and proteins in HuH7 cells may be attributed to a faster rate of early repli-
cation of filoviruses in HuH7 cells compared to the rate in R06E-J cells. The differences in replication velocities 
may contribute to the different susceptibilities of HuH7 cells and R06E-J cells to filovirus infection. However, it 
does not explain which differences in the cellular regulatory response mechanisms are responsible for the higher 
RNA synthesis rate in HuH7 cells. We observed few regulatory effects at 3 and 7 h p.i. However, more than 1,670 
genes were up- or down-regulated at 23 h p.i. in EBOV-infected HuH7 cells, whereas only 74 genes showed altered 
expression patterns in MARV-infected samples (Fig. 4A). Chemokine ligands (CXCL1 and CXCL5), transcrip-
tion factors (e.g., FOSL1, FOS, FOSB, ATF3), and genes with diverse functions (e.g., PPP1R15A, dual-specificity 
phosphatases (DUSPs)) were among the 55 genes that were most strongly regulated after filovirus infections in 
HuH7 cells (log2FC > 5, Figure ES2A). This finding is supported by previous reports11,14. Each gene can be viewed 
along with all relevant details at our webtool: www.rna.uni-jena.de/supplements/filovirus_human_bat/igo.php.
Differential expression of 2,500 genes. We aimed to answer three questions based on gene transcription 
levels: (1) What happens during filovirus infections in the host? (2) What are the differences in host-cell responses 
between EBOV and MARV infections? (3) What are the differences in how HuH7 and R06E-J cells respond after 
EBOV and MARV infections? Over 2,500 differentially expressed genes were found to be involved in the response 
to filovirus infections (Tables S4–S10). The most significant differentially expressed genes during the course of 
both EBOV and MARV infections between HuH7 and R06E-J cells include genes for transcription factors that 
regulate the expression of kinases and their antagonists and genes involved in ubiquitination processes (Fig. 4B). 
Although we confirmed the previously reported dysregulation of genes involved in coagulation11,12,14, these were 
not among the most differentially expressed genes.
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With the exception of a few genes, we confirmed previously observed data based on microarray analyses of 
EBOV-infected HuH7 cells12, human macrophages14 rhesus monkey cells13, and mouse cells11.
Regulation of transcription factors. Many transcription factors were found to be among the most dif-
ferentially expressed genes. Therefore, we assume that they play an important role in the changes observed after 
filoviral infection. To identify the regulatory factors that are responsible for the observed transcriptional changes 
after filoviral infection in HuH7 cells, we performed motif activity response analyses with MARA47. MARA infers 
the regulatory impact (also called activity) of a regulatory motif from the changes in expression of the predicted 
downstream genes (targets) of that motif. For a curated collection of ~190 mammalian transcription factor bind-
ing motifs and ~90 miRNA seed families, we found 76 and 38 motifs with a change in activity (z-value > 1.5) 
Figure 4. Significantly regulated genes in cells infected with EBOV or MARV. (A) Number of strongly 
regulated human genes after infection with EBOV or MARV. There were only a few genes that were significantly 
regulated (padj < 0.1) at 3 and 7 h p.i. in both EBOV- and MARV-infected cells compared with their expression 
in Mock-treated cells. At 23 h p.i., the number of regulated genes was higher (1,678) in EBOV-infected 
cells than in cells infected with MARV. Adding these ~1,600 strongly regulated genes to the findings from 
analyses comparing the different time points or viruses resulted in approximately 2,500 genes being identified 
as significantly differentially transcribed. (B) Heat map of row-scaled log2-fold changes in expression in 
infected HuH7 and R06E-J-samples against the corresponding Mock samples (e.g., column three shows the 
fold change between HuH7 Mock-treated cells and HuH7 EBOV-treated cells at 23 h p.i.). The input matrix is 
scaled within the rows to visualize changes in expression at the gene level. Fold changes are based on unique 
genome read counts of H. sapiens and R. aegyptiacus. Genes without a clear homologous sequence in the R. 
aegyptiacus genome or transcriptome assembly are marked with a star. We identified homologous locations 
(LOC107508087, LOC107515336, LOC107498547) for three genes that were not directly annotated in the R. 
aegyptiacus genome (EP300, RPS17L, MX1). These locations were identified using our de novo transcriptome 
assembly (red boxes). We indicated the molecular function of each gene based on the color scheme presented in 
(D). (C) Highly regulated genes in EBOV- and MARV-infected HuH7 and R06E-J cells. FC – log2-fold change 
based on DESeq normalized read counts. See Supplement (Tables S5 and S6) and corresponding entries for 
detailed information. (D) The PANTHER database (v11.0)96 was used to assign molecular functions to each 
of the 64 genes in (B) We further subdivided the dominant group of genes that we identified to have a general 
binding function. During filovirus infections, the most prominent regulatory effects were observed for genes 
encoding transcription factors, those regulating the NFκB and MAPK pathways, their DUSP inhibitors and 
growth factors (Figure ES2A and Tables S5 and S6, full tables in the electronic supplement). In addition, changes 
were also observed for genes that regulate protein translation (RPS17, PPP1R15A), ubiquitination (TRAF6, 
SQSTM1), autophagocytosis (SQSTM1) and cation transport (CHAC1, ATP2B4). We also observed the strong up-
regulation of genes that are involved in energy transfer (e.g., RASGEF1B). Details can be found in Tables S5–S8.
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in response to EBOV and MARV infections, respectively (see electronic supplement, Section ES5). Genes that 
are regulated by such motifs are involved in NFκB signaling or cell-cycle regulation (Fig. 5). Interestingly, we 
found that the FOS/JUN -motif has significantly increased activity after both EBOV and MARV infections. 
This result indicates that genes having FOS/JUN -motif binding sites in their promoter region are primarily 
up-regulated (Fig. 5). Consistent with this, transcription factors that are associated with this motif (e.g., FOSB) 
were up-regulated in infected cells (Fig. 4B). The transcription factor AP1, a homo or heterodimer of differen-
tially expressed FOS and JUN, plays important roles in different viral infections48,49. Other motifs, such as the 
KLF12- and the NRF1-associated motifs (Fig. 5), are more specific to EBOV and MARV, respectively, reflecting 
the differences in the impacts of theses two viruses on the transcriptional landscape of infected cells. In summary, 
we found various motifs, including the antiviral signaling-associated motif for NFκB, to have significant changes 
in activity (Fig. 5). For each motif, we provide associated regulators and target genes (Section ES5).
The antiviral mRNA response is mostly unchanged. Unexpectedly, apart from the effect on tran-
scription factors, the majority of genes and pathways that are relevant for viral infections did not demonstrate 
significant regulatory changes in response to filoviral infection (Section ES6). The majority of genes involved in 
innate immune responses (from Kuri et al.50) were either not expressed in the human cell cultures examined here 
or were only slightly differentially regulated during infection (Table S11). Consistent with this observation, some 
of these genes (e.g., IFITM1/2, OAS1-3) are not included in our bat transcriptome assembly, suggesting they were 
not transcribed. However, we did observe significantly different RNA levels for several bat homologs of innate 
immune response genes in filovirus-infected R06E-J cells in comparison with their levels in HuH7 cells. For 
example, DDX58 and ADAR demonstrated lower, and NMI higher, expression levels in EBOV-infected R06E-J 
cells (Table S11). The differences in the mRNA concentrations of these transcripts in infected HuH7 and R06E-J 
cells may play a role in the defense mechanisms that are active during filovirus infections. Genes encoding for 
proteins initiating pathways known to respond to viral infections, such as DDX58 (Figure ES6.8), NFκB (Figures 
ES6.10 and ES6.17), and MAPK pathways (Figures ES6.2–6.7), were not induced during filovirus infections in 
our study. Only those genes of the examined pathways that encode proteins that act as key players (see Fig. 4B,C) 
were up-regulated in EBOV-infected HuH7 cells relative to their expression in R06E-J cells.
The Ebola viral protein VP35 inhibits DDX58 signaling, which determines the outcome of infection in human 
cells51–53. We inspected the DDX58 pathway, which induces ISRE3, AP1 (FOS and JUN), NFκB and interferon 
β activation in cells54,55 (Figure ES6.8). Although we observed differences between HuH7 and R06E-J cells in 
the levels of DDX58 and ISYNA1 mRNA, all but one gene (IKKε) related to the DDX58 pathway were expressed, 
but they were not differentially affected. We noted an up-regulation of the FOS (38X) and JUN (9X) genes in 
EBOV-infected HuH7 cells 23 h p.i. (Fig. 4B). We observed no significant change in the genes specific to the 
DDX58 pathway at the transcriptomic level. We therefore assume that regulation of the DDX58 pathway at the 
transcriptomic level is not a driving factor leading to the frequent fatalities observed in humans, which are not 
observed in bats, subsequent to filoviral infection.
Figure 5. Motif activity response analysis. The table shows the top significant motifs after the infection of 
HuH7 cells with EBOV (red) or MARV (blue) compared with the response in Mock controls. Regulated motifs 
are predicted to target (1) the cell cycle (E2F1..5.p2) by down-regulating CDC6, PCNA and MCM6; (2) NFκB 
-signaling (NFKB1_REL_RELA.p2) by targeting CXCL isoforms, ELF3, NFκB isoforms, FOSL2 and JUN;  
(3) EGR1 expression in EBOV-infected cells (KLF12.p2, YY1.p2 and others); or (4) chromatin organization in 
MARV-infected cells (NRF1.p2, YY1.p2 and others). For selected motifs, the inferred activity changes (points + 
/− 1 SD) after EBOV or MARV infection relative to the corresponding Mock controls are shown for the different 
time points (3, 7 or 23 h p.i.) adjacent to and below the table. Selected regulatory motifs, the associated genes 
and their important targets (including their fold change between two time points) can be viewed in Section ES5 
and are summarized in File ES5D.
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We investigated the relationship of the DDX58 protein to other proteins at the mRNA level, such as TRIM25, 
which interacts with the DDX58 pathway56. TRIM-family proteins are induced by interferons and are involved 
in antiviral cellular responses57. We found that several members of the TRIM-family were up-regulated in 
EBOV-infected cells between 3–7 h p.i. but were down-regulated from 7–23 h p.i. (Table S12). The corresponding 
bat homologs were either not expressed (e.g., TRIM71) or were not significantly differentially expressed between 
R06E-J and HuH7 cells (e.g., TRIM25).
In line with previous reports58, our results show that filoviruses neither induce nor block apoptosis (Figure 
ES6.33), as genes involved in apoptosis were not significantly regulated during EBOV or MARV infections, with 
the exception of BBC3, which was up-regulated 9.6X in EBOV-infected HuH7 cells. However, it is important to 
note that both cell lines were immortalized, which may explain the minimal effects on genes involved in apoptosis.
The majority of host genes demonstrate a similar reaction after EBOV and MARV infection. 
The overall reaction of EBOV- and MARV-infected HuH7 cells at 3 h was similar to the reaction in R06E-J cells 
at 7 h (Fig. 6). The gene coverage-dependent plot illustrates the greater viral replication velocity in HuH7 cells 
when compared with the velocity in R06E-J cells. This response may be influenced by viral attachment and entry 
processes. We investigated the differences and similarities during filovirus infection in HuH7 and R06E-J cells.
HuH7. We determined that the majority of the host genes reacted in a similar manner in response to EBOV 
and MARV infections, which may explain the common symptoms caused by these viruses in humans. CYR61 
was among the most up-regulated genes in HuH7 cells and was usually highly expressed at 3 and 23 h p.i., which 
correspond to the periods of inflammation and wound repair, respectively59 (Figure ES4C). The cytokine genes 
IL8 and IL32 responded in both MARV- and EBOV-infected HuH7 cells, showing a significant up-regulation 
(Fig. 4B). IL32 expression can be induced by IL8 and is involved in the apoptosis of T cells in EBOV-infected 
patients60,61. It is also up-regulated in response to influenza A virus infections. The up-regulation of IL8 results in 
the activation of pro-inflammatory pathways62,63. We identified NRAV up-regulation 7 h p.i. This long non-coding 
RNA was recently reported as a key regulator of antiviral innate immunity that acts via the suppression of 
interferon-stimulated gene transcription64. We propose that a cellular component exists, in addition to the filovi-
ral inhibition of the innate immune system by VP24 and VP3565–69, that results in the same inhibition of innate 
immunity. At 23 h p.i. we identified several highly up- and down-regulated genes, which we were unable to cate-
gorize (see Section ES4). We also determined that ANXA3 was markedly up-regulated. Annexin A3 is an inhibitor 
of phospholipase A2 and possesses anti-coagulant properties70.
Figure 6. Common gene regulation patterns after filovirus infection. The scatter plots demonstrate the fold 
changes in expression as determined by DESeq of coding and non-coding RNAs in MARV- and EBOV-infected 
cells compared with expression in Mock controls 3, 7 and 23 h after EBOV and MARV infections. We observed 
similar expression patterns in HuH7 cells at 3h p.i. and in the bat cell line 7 h p.i., suggesting that the progress of 
filovirus infection is slower in R06E-J cells. The scatter plot derived from the differential expression analysis of 
HuH7 cells at 23 h p.i. shows the large number of differentially expressed genes. A detailed view of the figures 
(including genes outside of the plotted range of fold changes) can be found in the electronic supplement, Figure 
ES4B. Genes demonstrating a similar expression after infection with EBOV and MARV and with an 
>abs FC(log ( )) 12  are marked in red. Black line: y = x; Dotted line: regression line.
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Our data indicate an initial inflammatory response (3 h p.i.)50, followed by a repression of antiviral defenses (7 h p.i.) 
with the majority of up- and down-regulated gene expression occurring at 23 h p.i. in the HuH7 cells (Fig. 6).
R06E-J. R06E-J cells responded differently to filovirus infections than HuH7 cells. At 3 h p.i., we identified 
down-regulations of nuclear receptors involved in cell proliferation and differentiation (e.g., NR4A371), and the 
cell-cycle-regulating ubiquitin ligase ANAPC10, which controls the progression through mitosis72. BLCAP, which 
controls cell proliferation, apoptosis and the cell cycle73, was also down-regulated at 3 h p.i. HAVCR1 (previously 
known as TIM-1), which was down-regulated at 7 h p.i., is a receptor for many viruses, including filoviruses74 and 
Dengue virus75. We observed that various histone genes (e.g., HIST1H2B6, HIST1H1C) were down-regulated at 
23 p.i. This may be an epigenetic signal that could induce cell death. NPR3 was also down-regulated in R06E-J 
cells 23 h after filovirus infection. This gene is involved in the regulation of blood volume and pressure, cardiac 
function and some metabolic and growth processes76. Additional information about the significant co-regulation 
of genes occuring during filovirus infection in HuH7 and R06E-J cells can be found in Section ES4.
These findings may describe the major differences between human and bat cells that occur during filovirus 
infection.
Differences in host cell responses after EBOV and MARV infections. Out of the 35 examined path-
ways (Figures ES6.2–6.33), the JAK/STAT, PPP1R15A and DUSP pathways demonstrated significant differential 
regulation during infection (Fig. 7). However, these pathways did not demonstrate identical activities in both 
EBOV and MARV infections, and the responses of these pathways cannot explain the common disease symp-
toms9 induced by both viruses.
The JAK/STAT pathway. In EBOV-infected HuH7 cells, all genes coding for members of the JAK/STAT pathway 
were slightly induced between 3 and 7 h p.i. (Fig. 7A). However, the JAK/STAT system in R06E-J cells demon-
strated only a minimal response to EBOV and MARV infections. The EBOV protein VP24 has a negative impact 
on STAT1 signaling77–79, and STAT1/2 were found to be down-regulated at 23 h compared with their expres-
sion at 7 h p.i. in the HuH7 cell line. Downstream genes in this pathway, such as EP300 and PIM1, were highly 
Figure 7. Effects of filovirus infections on JAK/STAT, PPP1R15A, and DUSP pathways. (A) The JAK/STAT 
pathway. The JAK/STAT pathway shows a common trend in expression levels: STAT1, STAT2 and JAK2 were 
up-regulated (↑ ) between 3 and 7 h p.i. and then down-regulated (↓ ) between 7 and 23 h p.i. in EBOV-infected 
HuH7 cells. The cytokine receptor IFNGR2 is not regulated between 3 and 7 h (= ) and shows a 2X up-regulation 
between 7 and 23 h (2↑ ) (Figure ES6.22). (B) The PPP1R15A pathway. Growth arrest and DNA damage 34 
(GADD34, officially known as PPP1R15A) can be rapidly induced by several types of cellular stress. In R06E-J 
cells, PPP1R15A was slightly up-regulated (2X) due to EBOV infection after 23 h; in HuH7 cells, we observed 
a strong up-regulation (45X) in EBOV-infected cells and no up-regulation in MARV-infected cells. (C) The 
DUSP pathway. DUSP1, 8 and 10 demonstrate the highest specificity for MAPKs (MAPK14 and MAPK8). 
DUSP1 is localized in the nucleus, whereas DUSP8 and DUSP10 are also available in the cytosol. The nuclear 
DUSPs are thought to be inducible phosphatases87, and the implications of DUSPs during viral infections 
have been demonstrated for DUSP1, which is up-regulated during Epstein-Barr virus97 and vaccinia virus 
infections88. In response to the vaccinia virus, DUSP1 is actively involved in antiviral countermeasures of the 
host cell via the regulation of MAPK phosphorylation. Legend. Boxes indicate up/down-regulation from 3 to 7 
h and from 7 to 23 h p.i. in EBOV-infected HuH7 cells (red); MARV-infected HuH7 cells (green); and EBOV-
infected R06E-J cells (blue). For cases where the expression level changed by more than 15%, an arrow indicates 
the direction of regulation (↑ /↓ ). When the expression level changed by more than 100% (2-fold change in 
transcription), the number beside the arrow indicates the fold change. “= ” indicates expression changes of  
< 15%. Squares around gene names indicate differential expression within the HuH7 cell line (red), between 
EBOV- and MARV-infected cells (green) and between HuH7 and R06E-J cells (blue).
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up-regulated at 23 h at the mRNA level in EBOV-infected HuH7 cells (Fig. 4B). mRNA of the signaling receptor 
IFNGR2 was up-regulated, and mRNA of the interacting JAK2 was down-regulated at 23 h p.i. in EBOV-infected 
HuH7 cells. This regulation may be attributed to the activation of feedback from PIM1 via CISH to the receptor 
IFNGR280,81 on protein level.
MARV infections trigger a different reaction in HuH7 cells than do EBOV infections: the PIM1 mRNA and 
the receptor IFNGR2 are down-regulated (Fig. 7A). Most strikingly, while we currently do not know whether 
VP24 also interacts with STAT1 in bats, the complete JAK/STAT pathway is mostly unaffected at the mRNA level 
during EBOV infections in R06E-J cells (Figure ES6.22).
The PPP1R15A pathway. The expression of PPP1R15A was markedly up-regulated in EBOV-infected HuH7 
cells but only slightly induced in filovirus-infected R06E-J cells (Fig. 4B). We do not currently know how the 
activity of PPP1R15A is linked to EBOV or MARV infections. Figure 7B highlights this extreme differential 
expression (45X), which suggests that this gene may be a previously unidentified key player in the response of 
EBOV-infected HuH7 cells.
For MARV-infected HuH7 and R06E-J cells, we did not detect such a huge change in PPP1R15A mRNA 
levels. PPP1R15A is involved in the regulation of programmed cell death82, and genes involved in apoptosis 
were not deregulated (Figure ES6.33), which might be because only immortalized cell lines were used in these 
experiments. Another important activity of PPP1R15A is the negative feedback control it exerts on eIF2α phos-
phorylation, which regulates protein translation83. EIF2α was not significantly differentially expressed in our 
samples (Figure ES6.12). Protein kinase R, which phosphorylates eIF2α, was slightly up- and down-regulated 
in EBOV- and MARV-infected cells, respectively. It is possible that the previously described inhibition of 
mTOR by PPP1R15A84,85 is responsible for the fact that the mTOR pathway was not found to be active in the 
filovirus-infected HuH7 and R06E-J cell lines (Figure ES6.26).
The DUSP pathway. The most striking difference between EBOV-infected HuH7 and R06E-J cells was observed 
among the mRNAs encoding the various DUSPs, which represents a possible key to the contrasting innate 
immune responses of human and bat cells86,87 (Fig. 7C). An up-regulated expression of DUSP1 has been observed 
for vaccinia virus-infected cells88 and EBOV-infected human macrophages14. DUSPs are critical regulators of 
several cellular pathways because they inhibit central immune activator genes such as MAPK8, MAPK14 and 
MAPK1/3 (also known as ERK2/1)87. While the expression levels of these three immune activator genes did not 
change significantly p.i., the drastic up-regulation at 23 h p.i. of DUSP genes in HuH7 (up to 25X) but not R06E-J 
(up to 3X) cells is worth noting.
We hypothesize that the following sequence of events occurs during EBOV infections. Upon EBOV invasion 
of the host cells, an antiviral response is induced, including the activation of NFκB and MAPK. Genes of other 
innate immune response pathways (e.g., JAK/STAT, DDX58) are then suppressed. After EBOV infection, DUSPs 
are highly up-regulated in HuH7 cells, correlating with the down-regulation of MAPK8, MAPK1/3 and MAPK14 
mRNA levels. When translated, these genes are responsible for the innate immune response89. PPP1R15A plays 
a central role by binding to the receptor TGFBR1 and inhibiting additional components of the innate immune 
system. Compared with HuH7 cells, R06E-J cells demonstrate almost no or only a very slight up-regulation of 
PPP1R15A and DUSPs, very likely leading to a stable antiviral response. Furthermore, the mRNA levels of all 
JAK/STAT pathway genes in R06E-J cells remain constant during EBOV-infection compared with the levels in 
HuH7 cells. The viral protein VP24 inhibits STAT1 activity in humans, blocking signaling into the nucleus. We 
suggest that a possible feedback loop exists that increases the number of IFNGR2 receptors in HuH7 cells. The 
robust expression of interferon-stimulated genes could orchestrate the antiviral response of the infected cell90.
Differences in baseline expression levels between human and bat cell lines. To validate the 
RNA-Seq-derived read counts and observed differences in the baseline expression levels of certain genes between 
the HuH7 and R06E-J cell lines, we performed qRT-PCR analyses for the putative EBOV receptors NPC191 and 
HAVCR192 and the toll-like receptor TLR3 on Mock and EBOV samples 3 and 23 h p.i. (Section ES7). We com-
pared the 18S-normalized mRNA levels of these genes (File ES7B) with the RNA-Seq-derived read counts from 
human and bat cells and found a strong overall correlation. Based on our data, all three genes are expressed in 
both cell lines. We observed that NPC1 is clearly more abundant in HuH7 cells than in the R. aegyptiacus cell 
line. TLR3 is expressed at a greater level in R06E-J cells than in the human cell line, but was also not differentially 
expressed. These results support our RNA-Seq data. Interestingly, we observed differences in the melting curves 
for TLR3 and HAVCR1 (Figure ES7B), which could be due to differences in the amplified sequences of human 
and bat RNA as identical degenerate primers were used for the amplification of TLR3 from HuH7 and R06E-J 
cells. For HAVCR1 expression, we observed a slight down-regulation between 3 and 23 h p.i. in the R06E-J cells. 
However, further studies with different cell lines and primary cells are required.
We observed clear differences in the baseline expression of some genes between the HuH7 and R06E-J cell 
lines. However, we avoided the complications this issue may cause when comparing homologous human and bat 
genes by focused on the calculated log2-fold changes instead of directly comparing read counts.
The filovirus infection network. In analyzing the protein-level connections among the hundreds of sig-
nificantly up-regulated genes in relation to the connections at the transcriptional level and in regard to the differ-
ences in the analyzed pathways many specific and sometimes suprising relationships between key players were 
observed. We identified a vast and complex network of interacting host genes that may explain the fatal outcome 
of the EBOV and MARV infections. We have summarized the genes that are significantly regulated at the mRNA 
level in the “filovirus infection network” illustrated in Fig. 8. The connections shown are based on known protein/
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protein interactions from the literature. We summarized the differences between the different time points over the 
course of infections in HuH7 and R06E-J cells as well as between EBOV and MARV infections. This summary is 
not complete, because several highly regulated genes, such as SKP2, which inhibit CDKN1B, CYCE and CDKN1A 
were not connected in our filovirus infection network, probably because of missing information in the literature. 
When investigating other pathways, such as those involving MAPK, NFκB, focal adhesion, or TGFβ, we observed 
that the portions of the pathways that were active in the nucleus were differentially regulated between HuH7 and 
R06E-J cells during filovirus infections.
Conclusions
The Ebola and Marburg filoviruses cause severe and often fatal infection in humans, whereas bats, shown to be 
carriers, do not develop disease symptoms after infection. As a first step towards identifying the cellular response 
that allows bats to survive a filovirus infection, we provide a systematic overview of the genes that are differen-
tially expressed between human and bat cells during EBOV and MARV infections at three time points p.i. Our 
investigations are based on 18 full transcriptomic datasets.
In addition to the state-of-the-art RNA-Seq data analysis, comprising read counting, normalization and cal-
culations of fold changes, we investigated 1,500 genes (~7% of human genes) in detail, overlapping them with 
the 2,500 genes potentially affected during filovirus infections. For each gene, we investigated the following 
aspects: (1) gene synonyms, (2) functional information, (3) different isoforms, (4) characteristics in 5′ /3′ -UTR, 
(5) intronic transcripts, (6) single-nucleotide exchanges, (7) ncRNA detection, (8) description of novel genes, 
(9) genomic context, (10) conservation, (11) expression profile changes, and (12) homologous gene detection in 
R. aegyptiacus. The result of this multidimensional bioinformatics analysis is a comprehensive electronic supple-
ment (www.rna.uni-jena.de/supplements/filovirus_human_bat/igo.php) that provides quick insights into how 
individual genes of interest are regulated during EBOV and MARV infections via transcriptional changes and 
the generation of alternatively spliced forms. We were only able to investigate expression patterns in two immor-
talized cell lines of different tissue origin (humans, liver; bat, embryonic). The data collected and presented here 
Figure 8. The filovirus infection network. EBOV and MARV keyplayers in HuH7 and R06E-J cells on 
transcriptional level and their interactions on protein level are displayed. We combined significant differentially 
expressed genes from known pathways and the literature. Nearly all of the highly deregulated keyplayers of 
most significant pathways of this study (e.g. MAPK, NFκB, JAK/STAT and DUSP) are part of this filovirus 
infection network. We are not able to connect all genes (e.g. SKP2 inhibiting CDKN1B, CYCE and CDKN1A). 
We found seven members of the DUSP pathway (DUSP1, 4, 5, 6, 8, 10 and 16) being highly deregulated and 
involved in many interactions, mostly repressing MAPK8, MAPK1/MAPK3 and MAPK14. We found several 
transcription factors (e.g. FOS, JUN, ATF3) being up-regulated during EBOV infection on high levels. Cilloniz 
et al. performed global gene expression analysis of spleen samples of mice infected with different mouse-
adapted EBOVs11. Here, we mainly confirm the results for HuH7 cells. Yellow background—receptors and 
associated proteins; blue background—nuclear proteins; red boxes—significant differentially expression in 
HuH7 cells between 3, 7 and 23 h; green boxes—significant differentially expression between EBOV and MARV; 
blue boxes—significant differentially expression between HuH7 and R06E-J cells. A detailed picture, gene 
descriptions and gene regulations can be viewed at Figure ES6.1.
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serve as valuable sources of information for generating and testing hypotheses concerning the regulatory circuits 
that are active in filovirus-infected cells and may accelerate filovirus research.
EBOV and MARV replicate more rapidly in HuH7 cells than in R06E-J cells at the early stages of infection. 
This behavior is especially distinct for EBOV. This trend was confirmed based on the detection of larger quantities 
of viral nucleoproteins in HuH7 than in R06E-J cells as assessed via IFA. The slower replication rate of filoviruses 
in bat cells suggests that they have more time to establish a successful antiviral defense, whereas humans are 
almost immediately overwhelmed by the virus.
Transcription factors are the most differentially expressed genes in human cells after filovirus infection, and 
the activity of various transcription factor binding motifs changes after filoviral infection. Some of these changes 
are common to both filoviruses. However, other changes are specific to EBOV or MARV infections.
We mapped the differential expression data of single genes to known innate immune-response pathways 
and to those we found significantly enriched. Here, we report pathways that are strongly deregulated between 
EBOV-infected HuH7 and R06E-J cells. However, expected deregulated pathways, with commonalities in tran-
scriptional responses to EBOV and MARV infections but differences between HuH7 and R06E-J cells, were not 
observed overall. We condensed the data from this analysis into a single figure representing the filovirus infection 
network. This network provides valuable insights into previously undescribed interactions and responses to filo-
virus infections.
Although we examined the expression pattern of three genes (HAVCR1, NPC1, TLR3) by performing 
qRT-PCR analyses of the HuH7 and R06E-J cell lines, further investigations (e.g., in similar or different cell types, 
primary cells, or cells of the immune system) are required to improve the compiled data, as are in vivo studies on 
this topic.
We report a systematic and comprehensive computational study that provides a basis for further research into 
the pathogenesis of filoviruses and contributes significantly to the field of virology in general.
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